Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Siemens Healthcare Team on PCR-Based Molecular Dx Workflow

NEW YORK (GenomeWeb) – Thermo Fisher Scientific and Siemens Healthcare have announced a new strategic relationship to integrate Thermo Fisher's real-time PCR into Siemens' Versant kPCR molecular diagnostics platform.

The partners have already combined the technologies into a workflow that Siemens will display next week at the European Congress of Clinical Microbiology and Infectious Disease.

"We are excited to collaborate with Siemens in support of its Versant kPCR Molecular Solution as we work to expand our partnerships in the diagnostics space," Drew Burch, Thermo Fisher's head of licensing and commercial supply, said in a statement.

Thermo Fisher offers a real-time PCR ecosystem of reagents, instruments, and assays.

Siemens' Versant kPCR Molecular System has proved to be a platform upon which emerging infectious disease assays can be run. Last month, Siemens released a research-use-only Zika virus test, and in recent years other diagnostics firms have developed qPCR assays, such as a MERS test, that can run on Versant.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.